Kymera Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2019 | 5.8M |
| FY2020 | 52.0M |
| FY2021 | 48.0M |
| FY2022 | 53.9M |
| FY2023 | 58.4M |
| FY2024 | 75.0M |
| FY2025 | 84.5M |
| FY2026 | 81.6M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2019 | 5.8M |
| FY2020 | 52.0M |
| FY2021 | 48.0M |
| FY2022 | 53.9M |
| FY2023 | 58.4M |
| FY2024 | 75.0M |
| FY2025 | 84.5M |
| FY2026 | 81.6M |